At Emmes Group, we are proud to serve a global network of clients who share a commitment to advancing health through high-integrity research. From biopharmaceutical innovators and federal agencies to academic centers, non-profits, and foundations, our partners rely on us to bring science, strategy, and operational strength to their most important work.
Who We Serve
Biopharmaceutical Companies
We support biopharma organizations across the spectrum, from emerging biotech to established global firms, helping bring new therapies and treatments to life. Our services span clinical development phases, therapeutic areas, and regulatory pathways, backed by a legacy of scientific rigor and collaborative flexibility.
Government Agencies
With a long-standing history supporting U.S. and international government agencies, Emmes Group has played a leading role in clinical trials, epidemiological studies, and public health initiatives. We’ve supported research on high-priority diseases such as HIV/AIDS, Ebola, COVID-19, and influenza, and have worked with more than half of the NIH Institutes.
Non-Profit Organizations and Foundations
We proudly partner with mission-driven organizations that fund and lead critical research efforts. From rare disease to global health, we bring the structure and expertise to help non-profits and foundations deliver meaningful outcomes.
Academic and Research Institutions
Our collaborations with academic medical centers and universities extend promising research through large-scale, multicenter studies. We work side-by-side with investigators to apply the best scientific practices and modern clinical operations without compromising academic integrity.
Public-Private Partnerships
Emmes Group actively participates in public-private partnerships that bring together government, industry, academia, and non-profit stakeholders. These collaborations are a powerful force for innovation, enabling faster progress and broader impact across the research ecosystem.
Trusted by Organizations Worldwide
Our reach reflects the trust placed in us by organizations across sectors:
- 400+ clients served worldwide
- 200+ biopharmaceutical companies supported across all clinical phases
- 16 of the top 20 global pharmaceutical companies have partnered with Emmes Group
- 15 of 27 NIH Institutes supported through active or historic projects
- 100+ academic and non-profit collaborations
- 25+ public-private partnerships advanced
We’re honored to contribute to research that improves health, extends lives, and shapes the future of medicine.
“Emmes Group brings the rare ability to balance deep scientific expertise with practical, scalable execution. Their partnership model is built on integrity, collaboration, and an unwavering commitment to public health.”
Senior Director
Global Clinical Operations at mid-sized pharma company